Skip to content
AiSeekAiSeek
Sign in
Nexalin Technology Regains Nasdaq Listing ComplianceAI illustration
NewMarketsReported 2026-10-08 20:30

Nexalin Technology Regains Nasdaq Listing Compliance

Nexalin Technology, Inc. has regained compliance with Nasdaq’s minimum bid price requirement, following a decision by the Nasdaq Hearings Panel to grant the company’s request for continued listing.

Why it matters. Nexalin Technology’s regained compliance is crucial for maintaining its listing on Nasdaq and ensuring continued access to capital markets.

01

Who it touches

  1. 1Nexalin Technology, Inc.
  2. uses →Fact
    2frequency based bioelectronic medical technologyTechnology
  3. produces →Fact
    3neurostimulation productsProduct
02

Evidence

  • GGlobeNewswire public company newsCompany2026-10-08 20:30
    must demonstrate compliance with the minimum $2.5 million stockholders’ equity requirement under Nasdaq Listing Rule 5550(b)(1) on or before January 4, 2027.
    View source
  • GGlobeNewswire public company newsCompany2026-10-08 20:30
    the closing bid price of the Company’s common stock was above the $1.00 per share minimum for 21 consecutive trading days, from August 31 through September 29, 2026
    View source
  • GGDELT Global Knowledge GraphMedia2026-10-08 21:00
    View source
  • GGDELT Global Knowledge GraphMedia2026-10-08 23:15
    View source
  • GGDELT Global Knowledge GraphMedia2026-10-08 23:15
    View source
  • GGDELT Global Knowledge GraphMedia2026-10-08 23:15
    View source
  • GGDELT Global Knowledge GraphMedia2026-10-08 23:15
    View source